作者：
Anna R,Yousaf [1]
;
Margaret M,Cortese [2]
;
Allan W,Taylor [2]
;
Karen R,Broder [2]
;
Matthew E,Oster [3]
;
Joshua M,Wong [4]
;
Alice Y,Guh [2]
;
David W,McCormick [4]
;
Satoshi,Kamidani [5]
;
Elizabeth P,Schlaudecker [6]
;
Kathryn M,Edwards [7]
;
C Buddy,Creech [8]
;
Mary A,Staat [6]
;
Ermias D,Belay [2]
;
Paige,Marquez [2]
;
John R,Su [2]
;
Mark B,Salzman [9]
;
Deborah,Thompson [10]
;
Angela P,Campbell [2]
;
MIS-C Investigation Authorship Group
作者单位：
CDC COVID-19 Response Team, US Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: pgy6@cdc.gov.
[1]
CDC COVID-19 Response Team, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
[2]
Division of Cardiology, Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
[3]
CDC COVID-19 Response Team, US Centers for Disease Control and Prevention, Atlanta, GA, USA; Epidemic Intelligence Service, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
[4]
Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
[5]
Division of Infectious Diseases, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
[6]
Division of Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
[7]
Vanderbilt Vaccine Research Program, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
[8]
Kaiser Permanente West Los Angeles Medical Center, Los Angeles, CA, USA.
[9]
US Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, USA.
[10]
DOI
10.1016/S2352-4642(22)00028-1
PMID
35216660
发布时间
2024-09-09
换一批
换一批
